TRP2 (DCT) (NM_001922) Human Untagged Clone

CAT#: SC122613

DCT (untagged)-Human dopachrome tautomerase (dopachrome delta-isomerase, tyrosine-related protein 2) (DCT), transcript variant 1



  "NM_001922" in other vectors (6)

CNY 2,950.00


货期*
现货

规格
    • 10 ug

Cited in 1 publication.

Product images

经常一起买 (4)
Anti-DCT Rabbit Polyclonal Antibody
    • 100 ul

CNY 1,999.00
CNY 3,280.00


TurboFectin Transfection Reagent (1 mL in 1 vial)
    • 1 ml in 1 vial

CNY 4,090.00


DH5α Chemically Competent Cells (≥10^8 cfu/μg of pUC19 DNA)
    • 5 x 200 ul

CNY 1,280.00


Forward sequencing primer VP1.5, Reverse sequencing primer XL39, 100pmoles each
    • 100 pmol

CNY 480.00

Specifications

Product Data
Type Human Untagged Clone
Tag Tag Free
Synonyms TRP-2; TYRP2
Vector pCMV6-XL5
E. coli Selection Ampicillin (100 ug/mL)
Mammalian Cell Selection None
Sequence Data
>OriGene sequence for NM_001922 edited
CTCATTAAATTTGGTTGTTAGAGGCGCTTCTAAGGAAATTAAGTCTGTTAGTTGTTTGAA
TCACATAAAATTGTGTGTGCACGTTCATGTACACATGTGCACACATGTAACCTCTGTGAT
TCTTGTGGGTATTTTTTTAAGAAGAAAGGAATAGAAAGCAAAGAAAAATAAAAAATACTG
AAAAGAAAAGACTGAAAGAGTAGAAGATAAGGAGAAAAGTACGACAGAGACAAGGAAAGT
AAGAGAGAGAGAGAGCTCTCCCAATTATAAAGCCATGAGCCCCCTTTGGTGGGGGTTTCT
GCTCAGTTGCTTGGGCTGCAAAATCCTGCCAGGAGCCCAGGGTCAGTTCCCCCGAGTCTG
CATGACGGTGGACAGCCTAGTGAACAAGGAGTGCTGCCCACGCCTGGGTGCAGAGTCGGC
CAATGTCTGTGGCTCTCAGCAAGGCCGGGGGCAGTGCACAGAGGTGCGAGCCGACACAAG
GCCCTGGAGTGGTCCCTACATCCTACGAAACCAGGATGACCGTGAGCTGTGGCCAAGAAA
ATTCTTCCACCGGACCTGCAAGTGCACAGGAAACTTTGCCGGCTATAATTGTGGAGACTG
CAAGTTTGGCTGGACCGGTCCCAACTGCGAGCGGAAGAAACCACCAGTGATTCGGCAGAA
CATCCATTCCTTGAGTCCTCAGGAAAGAGAGCAGTTCTTGGGCGCCTTAGATCTCGCGAA
GAAGAGAGTACACCCCGACTACGTGATCACCACACAACACTGGCTGGGCCTGCTTGGGCC
CAATGGAACCCAGCCGCAGTTTGCCAACTGCAGTGTTTATGATTTTTTTGTGTGGCTCCA
TTATTATTCTGTTAGAGATACATTATTAGGACCAGGACGCCCCTACAGGGCCATAGATTT
CTCACATCAAGGACCTGCATTTGTTACCTGGCACCGGTACCATTTGTTGTGTCTGGAAAG
AGATCTCCAGCGACTCATTGGCAATGAGTCTTTTGCTTTGCCCTACTGGAACTTTGCCAC
TGGGAGGAACGAGTGTGATGTGTGTACAGACCAGCTGTTTGGGGCAGCGAGACCAGACGA
TCCGACTCTGATTAGTCGGAACTCAAGATTCTCCAGCTGGGAAACTGTCTGTGATAGCTT
GGATGACTACAACCACCTGGTCACCTTGTGCAATGGAACCTATGAAGGTTTGCTGAGAAG
AAATCAAATGGGAAGAAACAGCATGAAATTGCCAACCTTAAAAGACATACGAGATTGCCT
GTCTCTCCAGAAGTTTGACAATCCTCCCTTCTTCCAGAACTCTACCTTCAGTTTCAGGAA
TGCTTTGGAAGGGTTTGATAAAGCAGATGGGACTCTGGATTCTCAAGTGATGAGCCTTCA
TAATTTGGTTCATTCCTTCCTGAACGGGACAAACGCTTTGCCACATTCAGCCGCCAATGA
TCCCATTTTTGTGGTTCTTCATTCCTTTACTGATGCCATCTTTGATGAGTGGATGAAAAG
ATTTAATCCTCCTGCAGATGCCTGGCCTCAGGAGCTGGCCCCTATTGGTCACAATCGGAT
GTACAACATGGTTCCTTTCTTCCCTCCAGTGACTAATGAAGAACTCTTTTTAACCTCAGA
CCAACTTGGCTACAGCTATGCCATCGATCTGCCAGTTTCAGTTGAAGAAACTCCAGGTTG
GCCCACAACTCTCTTAGTAGTCATGGGAACACTGGTGGCTTTGGTTGGTCTTTTTGTGCT
GTTGGCTTTTCTTCAATATAGAAGACTTCGAAAAGGATATACACCCCTAATGGAGACACA
TTTAAGCAGCAAGAGATACACAGAAGAAGCCTAGGGTGCTCATGCCTTACCTAAGAGAAG
AGGCTGGCCAAGCCACAGTTCTGACGCTGACAATAAAGGAACTAATCCTCACTGTTCCTT
CTTGAGTTGAAGATCTTTGACATAGGTTCTTCTATAGTGATGATGATCTCATTCAGAAGA
TGCTTAGCTGTAGTTTCCGCTTTGCTTGCTTGTTTAACAAACCCAACTAAAGTGCTTGAG
GCTACCTCTACCTTCAAATAAAGATAGACCTGACAATTTGTGATATCTAATAATAACCCC
CCCCCAATATTGATTAAGCCTCCTCCTTTTCTGAAAGCATTTAAAAAAAAAAAAAAA
>OriGene 5' read for NM_001922 unedited
NNGGTGTTCAAAATTTGTAATACGACTCACTATAGGGCCGGCCGCGNAATTCCCGGATAT
CGTCGACCCACGCGTCCGCTCATTAAATTTGGTTGTTAGAGGCGCTTCTAAGGAAATTAA
GTCTGTTAGTTGTTTGAATCACATAAAATTGTGTGTGCACGTTCATGTACACATGTGCAC
ACATGTAACCTCTGTGATTCTTGTGGGTATTTTTTTAAGAAGAAAGGAATAGAAAGCAAA
GAAAAATAAAAAATACTGAAAAGAAAAGACTGAAAGAGTAGAAGATAAGGAGAAAAGTAC
GACAGAGACAAGGAAAGTAAGAGAGAGAGAGAGCTCTCCCAATTATAAAGCCATGAGCCC
CCTTTGGTGGGGGTTTCTGCTCAGTTGCTTGGGCTGCAAAATCCTGCCAGGAGCCCAGGG
TCAGTTCCCCCGAGTCTGCATGACGGTGGACAGCCTAGTGAACAAGGAGTGCTGCCCACG
CCTGGGTGCAGAGTCGGCCAATGTCTGTGGCTCTCAGCAAGGCCGGGGGCAGTGCACAGA
GGTGCGAGCCGACACAAGGCCCTGGAGTGGTCCCTACATCCTACGAAACCAGGATGACCG
TGAGCTGTGGCCAAGAAAATTCTTCCACCGGACCTGCAAGTGCACAGGAAACTTTGCCGG
CTATAATTGTGGAGACTGCAAGTTTGGCTGGACCGGTCCCAACTGCGAGCGGAAGAAACC
ACCAGTGATTCGGCAGAACATCCATTCCTTGAGTCCTCANGAAAGAGAGCAGTTCTTGGG
CGCCTTAGATCTCGCGAAGAGAGAGTACACCCCGACTACGTGATCACCACACAACACTGG
CTGGGCCTGCTTGGGCCCAATGGAACCAGCCGCAGTTTGCCAACTGCAGTGTTTATGATT
TTTTTGTGTGGCTCCATTAT
Restriction Sites Please inquire     
ACCN NM_001922
Insert Size 2157 bp
OTI Disclaimer Our molecular clone sequence data has been matched to the reference identifier above as a point of reference. Note that the complete sequence of our molecular clones may differ from the sequence published for this corresponding reference, e.g., by representing an alternative RNA splicing form or single nucleotide polymorphism (SNP).
Product Components The ORF clone is ion-exchange column purified and shipped in a 2D barcoded Matrix tube containing 10ug of transfection-ready, dried plasmid DNA (reconstitute with 100 ul of water).
Reconstitution 1. Centrifuge at 5,000xg for 5min.
2. Carefully open the tube and add 100ul of sterile water to dissolve the DNA.
3. Close the tube and incubate for 10 minutes at room temperature.
4. Briefly vortex the tube and then do a quick spin (less than 5000xg) to concentrate the liquid at the bottom.
5. Store the suspended plasmid at -20°C. The DNA is stable for at least one year from date of shipping when stored at -20°C.
Reference Data
RefSeq NM_001922.2, NP_001913.2
RefSeq Size 2291 bp
RefSeq ORF 1560 bp
Locus ID 1638
UniProt ID P40126
Protein Families Transmembrane
Protein Pathways Melanogenesis, Metabolic pathways, Tyrosine metabolism
Gene Summary Catalyzes the conversion of L-dopachrome into 5,6-dihydroxyindole-2-carboxylic acid (DHICA) (PubMed:8306979). Involved in regulating eumelanin and phaeomelanin levels.[UniProtKB/Swiss-Prot Function]
Transcript Variant: This variant (1) represents the more abundant transcript. Sequence Note: The RefSeq transcript and protein were derived from genomic sequence to make the sequence consistent with the reference genome assembly. The genomic coordinates used for the transcript record were based on alignments.
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Citations (1)

Other Versions

Customer Reviews 
Loading...